Cargando…
A random priming amplification method for whole genome sequencing of SARS-CoV-2 virus
BACKGROUND: Non-targeted whole genome sequencing is a powerful tool to comprehensively identify constituents of microbial communities in a sample. There is no need to direct the analysis to any identification before sequencing which can decrease the introduction of bias and false negatives results....
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148844/ https://www.ncbi.nlm.nih.gov/pubmed/35644636 http://dx.doi.org/10.1186/s12864-022-08563-z |
_version_ | 1784717095841300480 |
---|---|
author | Chrzastek, Klaudia Tennakoon, Chandana Bialy, Dagmara Freimanis, Graham Flannery, John Shelton, Holly |
author_facet | Chrzastek, Klaudia Tennakoon, Chandana Bialy, Dagmara Freimanis, Graham Flannery, John Shelton, Holly |
author_sort | Chrzastek, Klaudia |
collection | PubMed |
description | BACKGROUND: Non-targeted whole genome sequencing is a powerful tool to comprehensively identify constituents of microbial communities in a sample. There is no need to direct the analysis to any identification before sequencing which can decrease the introduction of bias and false negatives results. It also allows the assessment of genetic aberrations in the genome (e.g., single nucleotide variants, deletions, insertions and copy number variants) including in noncoding protein regions. METHODS: The performance of four different random priming amplification methods to recover RNA viral genetic material of SARS-CoV-2 were compared in this study. In method 1 (H-P) the reverse transcriptase (RT) step was performed with random hexamers whereas in methods 2–4 RT incorporating an octamer primer with a known tag. In methods 1 and 2 (K-P) sequencing was applied on material derived from the RT-PCR step, whereas in methods 3 (SISPA) and 4 (S-P) an additional amplification was incorporated before sequencing. RESULTS: The SISPA method was the most effective and efficient method for non-targeted/random priming whole genome sequencing of SARS-CoV-2 that we tested. The SISPA method described in this study allowed for whole genome assembly of SARS-CoV-2 and influenza A(H1N1)pdm09 in mixed samples. We determined the limit of detection and characterization of SARS-CoV-2 virus which was 10(3) pfu/ml (Ct, 22.4) for whole genome assembly and 10(1) pfu/ml (Ct, 30) for metagenomics detection. CONCLUSIONS: The SISPA method is predominantly useful for obtaining genome sequences from RNA viruses or investigating complex clinical samples as no prior sequence information is needed. It might be applied to monitor genomic virus changes, virus evolution and can be used for fast metagenomics detection or to assess the general picture of different pathogens within the sample. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12864-022-08563-z. |
format | Online Article Text |
id | pubmed-9148844 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-91488442022-05-31 A random priming amplification method for whole genome sequencing of SARS-CoV-2 virus Chrzastek, Klaudia Tennakoon, Chandana Bialy, Dagmara Freimanis, Graham Flannery, John Shelton, Holly BMC Genomics Research BACKGROUND: Non-targeted whole genome sequencing is a powerful tool to comprehensively identify constituents of microbial communities in a sample. There is no need to direct the analysis to any identification before sequencing which can decrease the introduction of bias and false negatives results. It also allows the assessment of genetic aberrations in the genome (e.g., single nucleotide variants, deletions, insertions and copy number variants) including in noncoding protein regions. METHODS: The performance of four different random priming amplification methods to recover RNA viral genetic material of SARS-CoV-2 were compared in this study. In method 1 (H-P) the reverse transcriptase (RT) step was performed with random hexamers whereas in methods 2–4 RT incorporating an octamer primer with a known tag. In methods 1 and 2 (K-P) sequencing was applied on material derived from the RT-PCR step, whereas in methods 3 (SISPA) and 4 (S-P) an additional amplification was incorporated before sequencing. RESULTS: The SISPA method was the most effective and efficient method for non-targeted/random priming whole genome sequencing of SARS-CoV-2 that we tested. The SISPA method described in this study allowed for whole genome assembly of SARS-CoV-2 and influenza A(H1N1)pdm09 in mixed samples. We determined the limit of detection and characterization of SARS-CoV-2 virus which was 10(3) pfu/ml (Ct, 22.4) for whole genome assembly and 10(1) pfu/ml (Ct, 30) for metagenomics detection. CONCLUSIONS: The SISPA method is predominantly useful for obtaining genome sequences from RNA viruses or investigating complex clinical samples as no prior sequence information is needed. It might be applied to monitor genomic virus changes, virus evolution and can be used for fast metagenomics detection or to assess the general picture of different pathogens within the sample. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12864-022-08563-z. BioMed Central 2022-05-30 /pmc/articles/PMC9148844/ /pubmed/35644636 http://dx.doi.org/10.1186/s12864-022-08563-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Chrzastek, Klaudia Tennakoon, Chandana Bialy, Dagmara Freimanis, Graham Flannery, John Shelton, Holly A random priming amplification method for whole genome sequencing of SARS-CoV-2 virus |
title | A random priming amplification method for whole genome sequencing of SARS-CoV-2 virus |
title_full | A random priming amplification method for whole genome sequencing of SARS-CoV-2 virus |
title_fullStr | A random priming amplification method for whole genome sequencing of SARS-CoV-2 virus |
title_full_unstemmed | A random priming amplification method for whole genome sequencing of SARS-CoV-2 virus |
title_short | A random priming amplification method for whole genome sequencing of SARS-CoV-2 virus |
title_sort | random priming amplification method for whole genome sequencing of sars-cov-2 virus |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148844/ https://www.ncbi.nlm.nih.gov/pubmed/35644636 http://dx.doi.org/10.1186/s12864-022-08563-z |
work_keys_str_mv | AT chrzastekklaudia arandomprimingamplificationmethodforwholegenomesequencingofsarscov2virus AT tennakoonchandana arandomprimingamplificationmethodforwholegenomesequencingofsarscov2virus AT bialydagmara arandomprimingamplificationmethodforwholegenomesequencingofsarscov2virus AT freimanisgraham arandomprimingamplificationmethodforwholegenomesequencingofsarscov2virus AT flanneryjohn arandomprimingamplificationmethodforwholegenomesequencingofsarscov2virus AT sheltonholly arandomprimingamplificationmethodforwholegenomesequencingofsarscov2virus AT chrzastekklaudia randomprimingamplificationmethodforwholegenomesequencingofsarscov2virus AT tennakoonchandana randomprimingamplificationmethodforwholegenomesequencingofsarscov2virus AT bialydagmara randomprimingamplificationmethodforwholegenomesequencingofsarscov2virus AT freimanisgraham randomprimingamplificationmethodforwholegenomesequencingofsarscov2virus AT flanneryjohn randomprimingamplificationmethodforwholegenomesequencingofsarscov2virus AT sheltonholly randomprimingamplificationmethodforwholegenomesequencingofsarscov2virus |